J. Safra Sarasin Holding AG lifted its position in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 145.4% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 68,190 shares of the biopharmaceutical company’s stock after purchasing an additional 40,399 shares during the period. J. Safra Sarasin Holding AG owned about 0.06% of Cytokinetics worth $2,253,000 as of its most recent SEC filing. now owns 1,156 shares of the biopharmaceutical company’s stock worth $46,000 after buying an additional 552 shares during the period. Cytokinetics Stock PerformanceCYTK stock opened at $56.97 on Friday.